This robotics company just put up another quarter of amazing growth, and the reasons to love the stock keep adding up.

This robotic surgical systems pioneer is dealing with a few issues, but its opportunities remain promising.

Intuitive Surgical, Inc. ISRG is expected to grow earnings by the double digits in 2026 and 2027. This Zacks Rank #1 (Strong Buy) is still the industry leader in robotic-assisted surgery. Intuitive ...

Intuitive Surgical (NASDAQ:ISRG) outlined what executives called a “strong year” in 2025, driven by multi-specialty procedure ...

On Tuesday, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories. The ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that ...

Intuitive Surgical’s ISRG third-quarter performance highlights a pivotal shift in its platform mix, with robotic bronchoscopy, formerly a peripheral initiative, rapidly emerging as a core growth ...

Great Falls Hospital unveiled a new diagnostic tool on Tuesday that is now available to patients in northcentral Montana for the first time. The Ion, a robotic device from the medical company ...

Intuitive Surgical Q4 2025 revenue rose 19% y/y; 2026 procedure guidance disappointed, but da Vinci 5 strength supports Buy—read now.